BARCELONA, Spain--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, will present new findings that showcase the benefits of its glucose biosensing technology for ...
Both were over-the-counter continuous glucose monitors (CGM) that would monitor the rise and fall of my glucose levels.
In December, online rumors hinted at the fact that Dexcom may be planning to sunset its G6 CGM sensor model. The company has now started to notify patients of the discontinuation plan. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results